Cytokeratin 5 anticorps
Aperçu rapide pour Cytokeratin 5 anticorps (ABIN285685)
Antigène
Voir toutes Cytokeratin 5 (KRT5) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Pureté
- Stabilized antiserum
-
Immunogène
- Cytokeratin 5 antibody was raised in guinea pig using recombinant human keratin K5 as the immunogen.
-
-
-
-
Indications d'application
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:5,000-1:10,000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Suppleid as a liquid with 0.09 % NaN3 and 0.5 % BSA.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4 °C
-
-
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." dans: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
: "p73 regulates epidermal wound healing and induced keratinocyte programming." dans: PLoS ONE, Vol. 14, Issue 6, pp. e0218458, (2019) (PubMed).
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." dans: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
-
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Autre désignation
- Cytokeratin 5
Antigène
-